A detailed history of Robeco Institutional Asset Management B.V. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 4,228 shares of CRL stock, worth $794,441. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,228
Previous 5,335 20.75%
Holding current value
$794,441
Previous $1.1 Million 24.5%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$187.96 - $245.29 $208,071 - $271,536
-1,107 Reduced 20.75%
4,228 $832,000
Q2 2024

Jul 22, 2024

SELL
$206.39 - $268.73 $159,539 - $207,728
-773 Reduced 12.66%
5,335 $1.1 Million
Q1 2024

Apr 24, 2024

BUY
$203.52 - $273.43 $561,308 - $754,119
2,758 Added 82.33%
6,108 $1.65 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $29,120 - $42,274
177 Added 5.58%
3,350 $791,000
Q4 2023

Feb 08, 2024

BUY
$164.52 - $238.84 $415,083 - $602,593
2,523 Added 388.15%
3,173 $3.35 Million
Q3 2023

Oct 23, 2023

SELL
$194.44 - $217.61 $19,638 - $21,978
-101 Reduced 13.45%
650 $127,000
Q2 2023

Jul 24, 2023

BUY
$183.71 - $210.25 $50,703 - $58,029
276 Added 58.11%
751 $157,000
Q1 2023

May 03, 2023

BUY
$191.89 - $259.92 $91,147 - $123,462
475 New
475 $95,000
Q3 2022

Dec 01, 2022

SELL
$182.44 - $250.54 $712,245 - $978,108
-3,904 Reduced 89.15%
475 $94,000
Q3 2022

Oct 26, 2022

SELL
$182.44 - $250.54 $712,245 - $978,108
-3,904 Reduced 89.15%
475 $94,000
Q2 2022

Dec 01, 2022

SELL
$204.13 - $302.4 $1.15 Million - $1.7 Million
-5,623 Reduced 56.22%
4,379 $938,000
Q2 2022

Jul 27, 2022

SELL
$204.13 - $302.4 $1.15 Million - $1.7 Million
-5,623 Reduced 56.22%
4,379 $938,000
Q1 2022

Dec 01, 2022

SELL
$255.51 - $362.11 $2.68 Million - $3.8 Million
-10,506 Reduced 51.23%
10,002 $2.84 Million
Q1 2022

Apr 26, 2022

SELL
$255.51 - $362.11 $2.68 Million - $3.8 Million
-10,506 Reduced 51.23%
10,002 $2.84 Million
Q4 2021

Dec 01, 2022

SELL
$351.38 - $448.68 $38,651 - $49,354
-110 Reduced 0.53%
20,508 $7.73 Million
Q4 2021

Jan 31, 2022

SELL
$351.38 - $448.68 $38,651 - $49,354
-110 Reduced 0.53%
20,508 $7.73 Million
Q3 2021

Dec 01, 2022

BUY
$372.64 - $458.3 $2.28 Million - $2.81 Million
6,125 Added 42.26%
20,618 $8.51 Million
Q3 2021

Oct 20, 2021

BUY
$372.64 - $458.3 $2.28 Million - $2.81 Million
6,125 Added 42.26%
20,618 $8.51 Million
Q2 2021

Dec 01, 2022

BUY
$294.17 - $371.65 $4.12 Million - $5.21 Million
14,018 Added 2951.16%
14,493 $5.36 Million
Q2 2021

Jul 28, 2021

BUY
$294.17 - $371.65 $4.26 Million - $5.39 Million
14,493 New
14,493 $5.36 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.